Overview

At the MOGAM Institute for Biomedical Research, we are committed to advancing the discovery of innovative therapeutics, grounded in a scientific understanding of life and powered by AI.

Even the smallest efforts must take root here, for a future we may never see.

Founding Chairman

MOGAM Young-sup Huh

Established in 1984 through the support of GC (formerly Green Cross), the institute stands as Korea’s first government-authorized private, non-profit research foundation.

At the time of its founding, launching an overseas institute or exploring alternative investments might have seemed a more favorable path. Yet, guided by the conviction that even the smallest efforts must take root in Korea, MOGAM was built on our own soil.

This decision reflected a profound determination to serve society, especially during an era when launching a private research foundation was far from easy.

Over the past four decades, we have fortified the landscape of life sciences in Korea. By synergizing our accumulated expertise with AI, we now accelerate the development of transformative therapies for patients in need.

This is our mission.

From the start of one discovery to broader scientific impact

2021 - Present

2010 - 2020

1984 - 2009

2021 - Present

FRONTIERFRONTIER

2010 - 2020

EVOLUTIONEVOLUTION

1984 - 2009

BEGINNINGBEGINNING

2024

06Appointment of Dr. Hyunjin Shin as 12th President

2022

04Appointment of Dr. Sun Kim as 11th President

2021

11Appointment of Dr. Hyunjin Shin as Vice President, Launch of an AI-driven drug discovery research institute

2020

03Development of varicella (chickenpox) vaccine, "BARYCELA Inj."

02Appointment of Dr. Jae-Wook Jeong as 10th President

2018

09Appointment of Dr. Eui-chul Cho as 9th President

2016

05Renamed the MOGAM Institute for Biomedical Research Foundation

2015

12Developed a highly pathogenic avian influenza vaccine (H5N1)

11Developed “GC Flu Quadrivalent,” a quadrivalent influenza vaccine

03Recipient of the Technology Award at the 16th Korea New Drug Development Award (“Neulapeg”)

02Appointment of Dr. Seung-hyun Choi as 8th President

2014

08Development of Neulapeg for the treatment of chemotherapy-induced neutropenia

2013

04Appointment of Eun-chul Huh, Ph.D as 7th President

2010

01Appointment of Il-sup Huh as 2nd Chairman

2009

12Recipient of the Minister’s Award for Health Industry Technology (Anti-angiogenic anticancer therapy)

2008

05Appointment of Dr. Yeop Yoon as 6th President

2005

03Redesignated as a WHO Collaborating Research Center (Vaccines and Diagnostic Reagents)

2000

11Appointment of Dr. Doo-Hong Park as 5th President

1996

10Appointment of Dr. Soo Il Jung as 4th President

1995

02Redesignated as a WHO Collaborating Research Center (Vaccines and Diagnostic Reagents)

1993

06Developed “Suduvax,” the world's second varicella vaccine

1992

05Appointment of Dr. Hong Mo Moon as 3rd President

1990

07Developed “Hantavax,” the world's first vaccine against epidemic hemorrhagic fever

1989

12Redesignated as a WHO Collaborating Research Center (Vaccines and Diagnostic Reagents)

05Appointment of Dr. Seung Bok Baek as 2nd President

1987

11Developed “HIVIRO ELISA,” Korea's first AIDS (HIV-1) diagnostic kit

1985

12Renamed the MOGAM Biotechnology Research Institute Foundation

1984

05Appointment of Dr. Kyung Ho Kim as 1st President

04Green Cross Research Institute Foundation established. First private non-profit research foundation approved by the Ministry of Science and Technology

Join MOGAM Institute's vision for humanity.

Go to Donate